Retrophin, Inc. (RTRX) - NASDAQ
  • Jason Napodano, CFA | Send Message 13 Jun

    Revive Therapeutics Targets Cystinuria With Bucillamine > $RVV.V $RVVTF < Very relevant to holders of $RTRX
      • Societe Financiers | Send Message 25 May

        Easy Trade of the Day: $RTRX breaks resistance
          • EP Vantage | Send Message 12 May

            Restoring Retrophin's Reputation $RTRX
              • Colin Macleod | Send Message 21 Jan

                3 Biotech Stocks The Top Fund of 2015 Thinks Investors Should Own Now $RTRX $PRTA $HZNP
                  • ValueWalk | Send Message 20 Jan

                    . @MartinShkreli Subpoenaed To Testify In Congress, Instead Trolls Twitter $RTRX $KBIOQQ
                      • ValueWalk | Send Message 14 Jan

                        KaloBios Pharmaceuticals Trading Resumes; Shares Collapse 80% $KBIO $KBIOQQ $RTRX
                          • ValueWalk | Send Message 8 Jan

                            Shkreli Investment Account Frozen, Current Value Unknown $KBIO $RTRX
                            Reply (1)
                            • tradebr2010 | Send Message 8 Jan
                              : 70% 0f 0 is still 0!
                              • ValueWalk | Send Message 30 Dec 2015

                                KaloBios (KBIO) Files For Bankruptcy After Ousting Shkreli $KBIO $RTRX
                                  • ValueWalk | Send Message 21 Dec 2015

                                    . @martinshkreli, TinFoil Hat On, Ousted From $KBIO $RTRX @MarkMelin fake #hedgefunds ?
                                      • ValueWalk | Send Message 21 Dec 2015

                                        . @MartinShkreli Claims US Government Out To Get Him Fake? #hedgefunds $RTRX $KBIO
                                          Company Description
                                          Retrophin, Inc. operates as a development stage company, which develops pharmaceutical products for the treatment of rare diseases. It currently focuses on the discovery and development of drugs for the treatment of debilitating and often life-threatening diseases for which there are currently... More
                                          Sector: Healthcare
                                          Industry: Biotechnology
                                          Country: United States